• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Molina Healthcare Inc

    11/12/24 12:53:29 PM ET
    $MOH
    Medical Specialities
    Health Care
    Get the next $MOH alert in real time by email
    SC 13G 1 SEC13G_Filing.htm SEC SCHEDULE 13G

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. _ )*

                

    Molina Healthcare, Inc.


    (Name of Issuer)

    Common Stock


    (Title of Class of Securities)

    60855R100


    (CUSIP Number)

    September 30, 2024


    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [X] Rule 13d-1(b)
    [ ] Rule 13d-1(c)
    [ ] Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.)


    CUSIP No. 60855R100

    1. NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

    Capital Research Global Investors
    95-1411037
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a) [ ]
    (b) [ ]
    3. SEC USE ONLY
    4. CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

    5. SOLE VOTING POWER 3,486,384
    6. SHARED VOTING POWER 0
    7. SOLE DISPOSITIVE POWER 3,490,747
    8. SHARED DISPOSITIVE POWER 0
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    3,490,747 Beneficial ownership disclaimed pursuant to Rule 13d-4
    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    [ ]
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    6.0%
    12. TYPE OF REPORTING PERSON

    IA

    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    


    Item 1.
    (a) Name of Issuer
    Molina Healthcare, Inc.
    (b) Address of Issuer's Principal Executive Offices
    200 Oceangate, Suite 100, Long Beach, CA 90802
    Item 2.
    (a) Name of Person Filing
    Capital Research Global Investors
    (b) Address of Principal Business Office or, if None, Residence
    333 South Hope Street, 55th Fl, Los Angeles, CA 90071
    (c) Citizenship
    N/A
    (d) Title of Class of Securities
    Common Stock
    (e) CUSIP Number
    60855R100
    Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
    (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
    (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
    (c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
    (d) [ ] Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
    (e) [X] An investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E);
    (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 240.13d-1(b)(1)(ii)(F);
    (g) [ ] A parent holding company or control person in accordance with Rule 240.13d-1(b)(1)(ii)(G);
    (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(J).
    Item 4. Ownership.
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
    (a) Amount Beneficially Owned:
    3,490,747 **
    (b) Percent of Class:
    6.0%
    (c) Number of shares as to which such person has:
    (i) sole power to vote or to direct the vote 3,486,384
    (ii) shared power to vote or to direct the vote 0
    (iii) sole power to dispose or to direct the disposition of 3,490,747
    (iv) shared power to dispose or to direct the disposition of 0
    **Capital Research Global Investors ("CRGI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CRGI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital Research Global Investors." CRGI is deemed to be the beneficial owner of 3,490,747 shares or 6.0% of the 58,600,000 shares believed to be outstanding.
    Item 5. Ownership of Five Percent or Less of Class.
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ ]
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
    Not Applicable
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
    Not Applicable
    Item 8. Identification and Classification of Members of the Group.
    Not Applicable. This schedule is not being filed pursuant to Rule 13d-1(b)(1)(ii)(J) or Rule 13d-1(d).
    Item 9. Notice of Dissolution of Group.

    Not Applicable
    Item 10. Certification.

    By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Capital Research Global Investors
    By: /s/ Donald H. Rolfe
    Date: November 07, 2024
    Name: Donald H. Rolfe
    Title: Senior Vice President and Senior Counsel, Fund Business Management Group, Capital Research and Management Company

    Get the next $MOH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $MOH

    DatePrice TargetRatingAnalyst
    7/25/2025$210.00Overweight → Neutral
    Cantor Fitzgerald
    7/25/2025$180.00Buy → Hold
    Truist
    7/10/2025$266.00Overweight → Equal-Weight
    Morgan Stanley
    6/9/2025$364.00Overweight
    Morgan Stanley
    4/22/2025$414.00Outperform
    Bernstein
    4/15/2025$375.00Outperform → Neutral
    Robert W. Baird
    3/5/2025$295.00 → $372.00Equal Weight → Overweight
    Wells Fargo
    12/17/2024$378.00 → $350.00Neutral
    Analyst
    More analyst ratings

    $MOH
    SEC Filings

    See more
    • SEC Form 10-Q filed by Molina Healthcare Inc

      10-Q - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

      7/24/25 9:49:15 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

      7/23/25 4:17:03 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

      7/7/25 6:31:21 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Molina Healthcare downgraded by Cantor Fitzgerald with a new price target

      Cantor Fitzgerald downgraded Molina Healthcare from Overweight to Neutral and set a new price target of $210.00

      7/25/25 8:59:40 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare downgraded by Truist with a new price target

      Truist downgraded Molina Healthcare from Buy to Hold and set a new price target of $180.00

      7/25/25 8:58:38 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Molina Healthcare from Overweight to Equal-Weight and set a new price target of $266.00

      7/10/25 8:36:12 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Operating Officer Woys James was granted 85 shares, increasing direct ownership by 0.13% to 64,331 units (SEC Form 4)

      4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      7/2/25 5:22:55 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Director Zoretic Richard C was granted 180 shares (SEC Form 4)

      4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      7/2/25 5:22:19 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Director Wolf Dale B was granted 180 shares (SEC Form 4)

      4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      7/2/25 5:21:24 PM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Molina Healthcare Reports Second Quarter 2025 Financial Results

      Revises Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2025 GAAP earnings per diluted share of $4.75 and adjusted earnings per diluted share of $5.48. Financial results are summarized below:   Three months ended   Six months ended   June 30,   June 30,   2025   2024   2025   2024                 (In millions, except per-share results) Premium Revenue $10,868   $9,446   $21,496   $18,950 Total Revenue $11,427  

      7/23/25 4:15:00 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces Preliminary Second Quarter Financial Results and Updates Fiscal Year 2025 Earnings Per Share Guidance

      Molina Healthcare, Inc. (NYSE:MOH) today announced preliminary financial results for the second quarter of 2025 and updated its full year 2025 adjusted earnings per share guidance. The Company's announcement of preliminary results was driven by recent market dynamics and off-cycle disclosures from others in the managed health care sector. The Company now expects its second quarter 2025 adjusted earnings to be approximately $5.50 per share(1), which is modestly below its prior expectations. This preliminary result reflects medical cost pressures in all three lines of business. The Company expects these medical cost pressures to continue into the second half of the year. As a result, the Co

      7/7/25 6:30:00 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces Second Quarter 2025 Earnings Release and Conference Call Dates

      Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the second quarter ending June 30, 2025, after the market closes on Wednesday, July 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, July 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 4784585. A telephonic replay of the conference call will be available through Thursday, July 31, 2025, by dialing (877) 344-7529 and entering the confirmation number, 9484867. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relation

      6/4/25 9:00:00 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Financials

    Live finance-specific insights

    See more
    • Molina Healthcare Reports Second Quarter 2025 Financial Results

      Revises Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2025 GAAP earnings per diluted share of $4.75 and adjusted earnings per diluted share of $5.48. Financial results are summarized below:   Three months ended   Six months ended   June 30,   June 30,   2025   2024   2025   2024                 (In millions, except per-share results) Premium Revenue $10,868   $9,446   $21,496   $18,950 Total Revenue $11,427  

      7/23/25 4:15:00 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces Preliminary Second Quarter Financial Results and Updates Fiscal Year 2025 Earnings Per Share Guidance

      Molina Healthcare, Inc. (NYSE:MOH) today announced preliminary financial results for the second quarter of 2025 and updated its full year 2025 adjusted earnings per share guidance. The Company's announcement of preliminary results was driven by recent market dynamics and off-cycle disclosures from others in the managed health care sector. The Company now expects its second quarter 2025 adjusted earnings to be approximately $5.50 per share(1), which is modestly below its prior expectations. This preliminary result reflects medical cost pressures in all three lines of business. The Company expects these medical cost pressures to continue into the second half of the year. As a result, the Co

      7/7/25 6:30:00 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces Second Quarter 2025 Earnings Release and Conference Call Dates

      Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the second quarter ending June 30, 2025, after the market closes on Wednesday, July 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, July 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 4784585. A telephonic replay of the conference call will be available through Thursday, July 31, 2025, by dialing (877) 344-7529 and entering the confirmation number, 9484867. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relation

      6/4/25 9:00:00 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Molina Healthcare Inc

      SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/14/24 1:22:34 PM ET
      $MOH
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by Molina Healthcare Inc

      SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/12/24 12:53:29 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Molina Healthcare Inc

      SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/8/24 10:34:33 AM ET
      $MOH
      Medical Specialities
      Health Care